Sale!

SLC29A3 Gene Histiocytosis-Lymphadenopathy Plus Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SLC29A3 Gene Histiocytosis-Lymphadenopathy Plus Syndrome NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the SLC29A3 gene responsible for a rare multisystem disorder affecting bones, skin, and immune function. Using next-generation sequencing technology, this comprehensive test provides definitive diagnosis for patients presenting with histiocytosis, lymphadenopathy, and associated symptoms. The test is particularly valuable for individuals with unexplained bone lesions, skin abnormalities, and recurrent infections. Results help guide personalized treatment strategies and provide crucial information for family planning. Available for only $500 USD, this advanced genetic testing offers peace of mind and clear diagnostic direction for complex medical cases.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SLC29A3 Gene Histiocytosis-Lymphadenopathy Plus Syndrome NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Multisystem Disorders

The SLC29A3 Gene Histiocytosis-Lymphadenopathy Plus Syndrome NGS Genetic DNA Test represents a breakthrough in diagnostic precision for patients presenting with complex multisystem symptoms. This advanced genetic test utilizes next-generation sequencing technology to identify mutations in the SLC29A3 gene, which plays a critical role in cellular nucleoside transport and immune system regulation.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets the SLC29A3 gene, which encodes the equilibrative nucleoside transporter 3 (ENT3) protein. Mutations in this gene disrupt normal cellular function and are directly linked to:

  • Histiocytosis-lymphadenopathy plus syndrome (HLPS)
  • Familial Rosai-Dorfman disease
  • H syndrome with associated bone and skin manifestations
  • Pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome
  • Multisystem inflammatory disorders affecting bones, skin, and immune function

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals presenting with the following symptoms or clinical findings:

  • Unexplained bone lesions or skeletal abnormalities
  • Persistent lymphadenopathy (swollen lymph nodes)
  • Recurrent skin rashes, hyperpigmentation, or hypertrichosis
  • Hearing loss or sensorineural impairment
  • Short stature or growth abnormalities
  • Recurrent infections suggesting immune dysfunction
  • Cardiac abnormalities or heart murmurs
  • Diabetes mellitus with unusual presentation
  • Family history of similar multisystem disorders

Clinical Benefits of Genetic Testing

Undergoing the SLC29A3 genetic test provides numerous clinical advantages:

  • Definitive Diagnosis: Eliminates diagnostic uncertainty and provides clear genetic confirmation
  • Personalized Treatment: Enables targeted therapeutic approaches based on specific genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management of potential complications
  • Comprehensive Care: Guides multidisciplinary treatment involving dermatology, immunology, and orthopedics

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and medical specialists:

  • Positive Result: Indicates the presence of pathogenic mutations in the SLC29A3 gene, confirming the diagnosis and guiding specific treatment protocols
  • Negative Result: Suggests that SLC29A3 mutations are not responsible for the clinical symptoms, directing further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation and possibly family studies
  • Carrier Status: Determines if an individual carries one copy of a mutated gene, important for family planning considerations

Test Information and Pricing

Test Component Details
Test Name SLC29A3 Gene Histiocytosis-Lymphadenopathy Plus Syndrome NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Accessibility and Convenience

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our comprehensive network ensures that advanced genetic testing is accessible to patients nationwide.

Take the Next Step Toward Clarity

Don’t let diagnostic uncertainty delay your path to proper treatment. Our experienced genetic counselors and medical specialists are ready to guide you through the testing process and help interpret your results. Contact us today to schedule your genetic counseling session and arrange for testing.

Call or WhatsApp: +1(267) 388-9828

Book your SLC29A3 genetic test today and take the first step toward definitive diagnosis and personalized treatment planning. Our team is committed to providing exceptional care and comprehensive support throughout your genetic testing journey.